角膜移植の市場規模、シェア、成長分析、タイプ別、適応症別、エンドユーザー別、地域別 - 産業予測 2025-2032年

角膜移植市場規模は、2023年に4億8,999万米ドルと評価され、2024年の5億2,674万米ドルから2032年には9億3,943万米ドルに成長し、予測期間中（2025年～2032年）のCAGRは7.5％で成長する見通しです。

米国国立衛生研究所（NIH）の最近の知見によると、円錐角膜患者の10～15％が治療の過程で角膜移植術を必要としています。これは、一般的な眼疾患である円錐角膜を効果的に管理する上で、角膜インプラントの重要な役割を強調しています。さらに、角膜失明は世界の健康上の大きな課題であり、緑内障、白内障に次いで失明原因の第3位にランクされ、世界中で推定1,000万人が影響を受けています。角膜インプラントの革新的なソリューションと進歩のための重要な市場機会は、ヘルスケアシステムがこの多くの患者のニーズに対応し、世界規模で角膜失明の結果と闘うために必要であることが、このデータから明らかになりました。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 技術分析

角膜移植市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 全層角膜移植
• 内皮角膜移植
• デスメ膜剥離自動角膜内皮移植術（DSAEK）
• 角膜移植
• 角膜輪部幹細胞移植
• その他

角膜移植市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• 真菌性角膜潰瘍
• 水疱性角膜症
• 円錐角膜
• 角膜炎
• 角膜実質ジストロフィー
• その他

角膜移植市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 眼科クリニック
• その他

角膜移植市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• CorneaGen（USA）
• Eversight（USA）
• Lions VisionGift（USA）
• Keramed Inc.（USA）
• EyeYon Medical（Israel）
• Aurolab（India）
• Presbia PLC（Ireland）
• Mediphacos（Brazil）
• DIOPTEX GmbH（Austria）
• AJL Ophthalmic S.A.（Spain）
• Florida Lions Eye Bank（USA）
• Ocular Systems Inc.（USA）
• Gebauer Medizintechnik GmbH（Germany）
• Tomey Corporation（Japan）
• SightLife（USA）
• Ampleye（Netherlands）
• Allotex（USA）
• Eye Bank Association of America（EBAA）（USA）
• Boston Keratoprosthesis（Boston KPro）（USA）
• IOPtima Ltd.（Israel）

結論と提言

Corneal Transplant Market size was valued at USD 489.99 million in 2023 and is poised to grow from USD 526.74 million in 2024 to USD 939.43 million by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Recent findings from the National Institutes of Health (NIH) indicate that 10-15% of keratoconus patients require corneal implant procedures during their treatment journey. This highlights the critical role of corneal implants in effectively managing keratoconus, a prevalent ocular condition. Additionally, corneal blindness poses a significant global health challenge, ranking as the third leading cause of blindness after glaucoma and cataracts, impacting an estimated 10 million individuals worldwide. The data reveals a vital market opportunity for innovative solutions and advancements in corneal implants, as healthcare systems seek to address the needs of this substantial patient population and combat the consequences of corneal blindness on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segments Analysis

Global Corneal Transplant Market is segmented by Type, Indications, End-User and region. Based on Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant and Others. Based on Indications, the market is segmented into Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others. Based on End-User, the market is segmented into Hospital, Eye Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Corneal Transplant Market

One of the key market drivers for the global corneal transplant market is the rising prevalence of corneal diseases and conditions, such as keratoconus, corneal scarring, and endothelial dysfunction. As aging populations increase worldwide, the incidence of these eye disorders is also growing, leading to a higher demand for corneal transplantation procedures to restore vision and improve quality of life. Additionally, advancements in surgical techniques and technologies, such as femtosecond laser-assisted surgery and improved preservation methods for donor corneas, are enhancing the success rates of transplants, further propelling market growth as healthcare providers seek effective treatment options for patients.

Restraints in the Corneal Transplant Market

The growth of the corneal transplant market is hindered by several notable constraints, primarily the high costs associated with the procedure and a limited supply of donor corneas. The financial implications of corneal transplantation, which include expenses related to pre-operative evaluations, surgical procedures, and subsequent post-operative care, create a substantial economic burden for both patients and healthcare systems. These elevated costs can restrict access to treatment, especially in areas with limited healthcare resources, thereby impeding the overall expansion of the market. Additionally, the scarcity of available donor material further exacerbates these challenges, making it difficult for the market to flourish.

Market Trends of the Corneal Transplant Market

The corneal transplant market is witnessing remarkable growth driven by technological advancements and an increasing geriatric population. Innovative corneal implants are enhancing the treatment's efficacy for eye disorders, particularly as conditions like Fuchs' dystrophy become more prevalent among individuals over 40. The aging demographic underscores a rising need for effective solutions to age-related eye diseases, propelling market demand. Additionally, greater awareness of corneal health and improved surgical techniques further bolster this trend. As such, the corneal transplant market is positioned for continued expansion, characterized by a surge in transplantation procedures and the development of next-generation implants.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Corneal Transplant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others

Global Corneal Transplant Market Size by Indications & CAGR (2025-2032)

• Market Overview
• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Corneal Stromal Dystrophies
• Others

Global Corneal Transplant Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospital
• Eye Clinics
• Others

Global Corneal Transplant Market Size & CAGR (2025-2032)

• North America (Type, Indications, End-User)
  • US
  • Canada
• Europe (Type, Indications, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indications, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indications, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indications, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversight (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lions VisionGift (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keramed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gebauer Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tomey Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SightLife (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ampleye (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allotex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Bank Association of America (EBAA) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Keratoprosthesis (Boston KPro) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOPtima Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations